Future Medicine has announced that its Oncology Management Series will be following a fully open access model, from January 2018. The eight journals within the Oncology Management Series are Breast Cancer Management; CNS Oncology; Colorectal Cancer; Hepatic Oncology; International Journal of Endocrine Oncology; International Journal of Hematologic Oncology; Lung Cancer Management and Melanoma Management.
The transition means that all content published from January 2018 onwards will be open access on www.futuremedicine.com. Access to all archive material is free for members of Oncology Central, an online oncology knowledge hub.
The journals cover key areas of oncology, publishing the latest findings and opinions related to the overall management of the respective disease areas. They explore the best patient-centered clinical research and present this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journals also highlight significant advances in basic and translational research, placing them in context for future therapy.
The Oncology Management Series of journals considers original research articles that have been conducted with scientific rigour and research integrity. They also accept case report submissions. Other article types considered include reviews, perspectives, editorials and commentaries, providing oncologists and other health professionals with high-quality information and discussion on these widespread diseases in a clear, accessible format. In addition, they also consider article proposals from nurse practitioners, patient advocates and the wider professional oncology community.
The journals will follow a gold open access model, publishing all articles under the Creative Commons CC-BY license to allow maximum dissemination. Authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3. All research and review-style articles submitted to the journals will undergo double-blind peer review by a minimum of three independent experts.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
